Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid in Patients at High Risk for Blood Transfusion After Spine Surgery

NCT03849443 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT03849443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03849443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid in Patients at High Risk for Blood Transfusion After Spine Surgery
Lead sponsor
Rush University Medical Center
Phase
Phase 1
Overall status
Recruiting
Start date
August 26, 2019
Completion date
January 1, 2027
Enrollment
604 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

open posterior thoracolumbar spinal fusion procedure